Skip to main content
. 2019 Sep 6;19:890. doi: 10.1186/s12885-019-6114-2

Table 1.

Univariable analysis for progression-free survival

Univariable
Factors Category Univariable analysis
HR (95% CI) p-value
Sex Female (vs. Male) 0.61 (0.27–1.38) 0.23
Age (Years) ≥40 (vs. < 40) 2.04 (0.76–5.47) 0.16
Performance Status 1 (vs. 0) 1.11 (0.46–2.69) 0.81
Histological subtype Leiomyosarcoma (vs. UPS) 0.59 (0.18–1.98) 0.40
Synovial sarcoma (vs. UPS) 0.34 (0.10–1.12) 0.08
Others (vs. UPS) 0.64 (0.24–1.72) 0.38
Tumor differentiation 3 (vs. 2) 0.64 (0.29–1.43) 0.28
Tumor necrosis 1 or 2 (vs. 0) 1.28 (0.56–2.93) 0.56
Tumor mitosis 2 or 3 (vs. 1) 1.14 (0.51–2.57) 0.75
Histological grade (FNCLCC) Grade 3 (vs. 2) 0.94 (0.42–2.09) 0.87
Histological grade (Ki-67) Grade 3 (vs. 2) 1.38 (0.61–3.12) 0.43
Tumor size > 10 cm (vs. < 10 cm) 3.15 (1.37–7.21) 0.0067

Abbreviations: HR hazard ratio, CI confidence interval, UPS, undifferentiated pleomorphic sarcoma, FNCLCC French Federation of Cancer Center